SCHEMBL18178775

SCHEMBL18178775

CCC(=O)Oc1cccc(CS)c1COc1cc(C)c(C)cc1C(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.31
ACLY P53396 1/20 0.31
MRGPRX4 Q96LA9 3/20 0.31
GUCY1B2 O75343 5/20 0.30
GUCY1A2 P33402 5/20 0.30
GUCY1A1 Q02108 5/20 0.30
GUCY1B1 Q02153 5/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178600 0.93 MRGPRX4 (0.34) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178777 0.92 ACHE (0.36) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178705 0.92 MRGPRX4 (0.35) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178779 0.90 ACHE (0.35) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178406 0.89 FABP4 (0.33) KDM4EHPGDHSD17B10LMNAGAA
SCHEMBL18178507 0.88 MRGPRX4 (0.34) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178776 0.88 SLC22A12 (0.40) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178756 0.88 NPSR1 (0.39) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18178712 0.87 MRGPRX4 (0.37) ACHEKDM4EHPGDHSD17B10KMT2A
SCHEMBL18182471 0.87 ACHE (0.36) ACHEKDM4EHPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 ACHE 460/4885KDM4E 2107/4885HPGD 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.